|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Bluebird Bio, Inc. (BLUE) |
|
|
$4.97 0.00 (0.00%) as of 4:30 Thu 5/29
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
194,444,000 |
| Market
Cap: |
966.39(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.29 - $27 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
2,674 |
42,255 |
99,473 |
| Total Sell Value |
$0 |
$13,099 |
$33,481 |
$161,950 |
| Total People Sold |
0 |
4 |
4 |
5 |
| Total Sell Transactions |
0 |
9 |
13 |
25 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jones-Burton Charlotte |
|
– • – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,245) |
0 |
|
- |
|
| Sterling O. James |
Chief Financial Officer |
• – – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,500) |
0 |
|
- |
|
| Sterling O. James |
Chief Financial Officer |
• – – |
2025-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| Colvin Richard A |
Chief Medical Officer |
• – – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,666) |
0 |
|
- |
|
| Colvin Richard A |
Chief Medical Officer |
• – – |
2025-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| Vittiglio Joseph |
Chief Business & Legal Officer |
• – – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,625) |
0 |
|
- |
|
| Vittiglio Joseph |
Chief Business & Legal Officer |
• – – |
2025-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| Vachon Mark |
|
– • – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,245) |
0 |
|
- |
|
| Tita-Reid Najoh |
|
– • – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,245) |
0 |
|
- |
|
| Paulson Richard A. |
|
– • – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,323) |
0 |
|
- |
|
| Agwunobi John O |
|
– • – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,245) |
0 |
|
- |
|
| Leiderman Elisabeth |
|
– • – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,245) |
0 |
|
- |
|
| Cloonan Michael |
|
– • – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,867) |
0 |
|
- |
|
| Leschly Nick |
|
– • – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,245) |
0 |
|
- |
|
| Klima Thomas J |
See Remarks |
• – – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,964) |
0 |
|
- |
|
| Klima Thomas J |
See Remarks |
• – – |
2025-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| Obenshain Andrew |
President and CEO |
• • – |
2025-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(24,120) |
0 |
|
- |
|
| Obenshain Andrew |
President and CEO |
• • – |
2025-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,820 |
14,820 |
|
- |
|
| Jones-Burton Charlotte |
|
– • – |
2025-05-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(928) |
1,245 |
|
- |
|
| Colvin Richard A |
Chief Medical Officer |
• – – |
2025-05-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,552) |
4,166 |
|
- |
|
| Vittiglio Joseph |
Chief Business & Legal Officer |
• – – |
2025-05-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,143) |
3,125 |
|
- |
|
| Vachon Mark |
|
– • – |
2025-05-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,252) |
1,245 |
|
- |
|
| Tita-Reid Najoh |
|
– • – |
2025-05-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,163) |
1,245 |
|
- |
|
| Paulson Richard A. |
|
– • – |
2025-05-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(155) |
1,323 |
|
- |
|
| Agwunobi John O |
|
– • – |
2025-05-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,323) |
1,245 |
|
- |
|
771 Records found
|
|
Page 1 of 31 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
